OpiCalc Logo

OpiCalc

--- Clinical Tools

Logo
OpiCalc
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk

VBAC Success Probability

Clinical Metrics

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

When to Use

  • Antenatal counseling for patients with one prior low-transverse cesarean section (LTCS) contemplating Trial of Labor After Cesarean (TOLAC).
  • Standardizing shared decision-making regarding mode of delivery at 37 0/7 to 41 6/7 weeks gestation.
  • Informing patients of their individualized probability of successful vaginal birth versus repeat cesarean.

Patient Selection

  • Single prior low-transverse uterine incision.
  • Singleton pregnancy.
  • Cephalic presentation.
  • Term gestation (≥37 weeks).

Absolute Contraindications to TOLAC

Do not use this calculator or attempt TOLAC if: Prior classical or T-shaped uterine incision, prior uterine rupture, extensive transfundal uterine surgery (e.g., myomectomy), or any standard contraindication to vaginal delivery (e.g., placenta previa).

CLINICAL INSIGHT

How it Works

Scoring Variables (2021 Race-Neutral Model)

Maternal Age
BMI
Prior Vaginal Delivery
Prior Arrest Disorder
Chronic Hypertension

Physiological Rationale

The model utilizes a logistic regression equation. Prior vaginal delivery is the strongest positive predictor of success, reflecting a "proven" pelvis. Conversely, a prior CS performed for an arrest disorder (failure to progress or fail to descend) suggests a recurring mechanical or physiological barrier, reducing the likelihood of success in subsequent trials.

The "Race-Neutral" Update

The 2021 revision (Grobman et al.) removed race and ethnicity as variables. The updated model provides similar predictive accuracy (AUC 0.71) without codifying social constructs as biological determinants, addressing historical disparities where Black and Hispanic patients were assigned lower success probabilities.

CLINICAL INSIGHT

Practical Pearls

Critical Insights

  • Prior VBAC is the single best predictor of future success (rates often >90%).
  • The calculator is most accurate for patients who enter labor spontaneously.
  • A success probability of >60-70% is generally considered "favorable" for a trial of labor.

Limitations & Caveats

  • Does not account for induction of labor — induction reduces success rates by ~10-15% compared to spontaneous labor.
  • Inter-pregnancy interval < 18 months significantly increases risk of uterine rupture.
  • Estimated fetal weight (EFW) > 4000g decreases probability of success but is not a variable in this specific model.
CLINICAL INSIGHT

Next Steps

Favorable Probability (>70%)

  • Counsel patient on the high likelihood of successful vaginal delivery.
  • Discuss the benefit-risk ratio: Lower maternal morbidity compared to repeat CS if successful.
  • Document shared decision-making for TOLAC.
  • Ensure facility allows for "immediate" emergency CS should rupture occur.

Uterine Rupture Risk (TOLAC vs. ERCD)

TOLAC (Success)
TOLAC (Failure)
Induction of Labor
Spontaneous Labor

The "Danger Zone"

The risk of uterine rupture is significantly higher if the prior cesarean was performed less than 18 months ago, or if prostaglandins (misoprostol) are used for induction.

Unfavorable/Low Probability (<60%)

  • Counsel patient that while VBAC is still possible, the risk of "failed" TOLAC is higher.
  • Explain that a failed TOLAC (maternal morbidity) is riskier than a scheduled repeat CS.
  • Consider Elective Repeat Cesarean Delivery (ERCD) if the patient prioritizes avoiding labor or failed trial.

Related Tools

CLINICAL INSIGHT

Evidence Base

Foundational Model

Development of a nomogram for prediction of vaginal birth after cesarean delivery.

Grobman WA, Lai Y, Landon MB, et al.Obstet Gynecol.2007

Race-Neutral Validation

Prediction of Vaginal Birth After Cesarean Delivery in North America: A Race-Neutral Algorithm.

Grobman WA, Sandoval G, Rice MM, et al.Obstet Gynecol.2021

Guideline Reference

ACOG Practice Bulletin No. 205 (Vaginal Birth After Cesarean Delivery) recommends the use of validated scoring systems like this MFMU model to assist in counseling and shared decision-making.

CLINICAL INSIGHT

Background

The MFMU Network

The Maternal-Fetal Medicine Units (MFMU) Network was established by the NICHD to conduct large-scale clinical trials in obstetrics. This calculator is the result of massive multi-center data collection aimed at reducing the rising primary cesarean rate in the US.

Dr. William Grobman

A leading figure in MFM and obstetric health services research. Dr. Grobman championed the removal of race from clinical algorithms to ensure that evidence-based tools do not inadvertently reinforce health inequities.